Selected article for: "alveolar damage and rapidly spread"
Author: Shan, Shi; Guangming, Li; Wei, Lei; Xuedong, Yang
Title: Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema in COVID-19: case report and literature review
  • Cord-id: h5lvk6k8
  • Document date: 2020_10_9
    • ID: h5lvk6k8
    Snippet: Coronavirus Disease 2019 (COVID-19) has rapidly spread worldwide. Numerous studies have shown its typical and atypical CT findings. We report one COVID-19 patient who presented with a transient pneumothorax, spontaneous pneumomediastinum (SP), as well as subcutaneous emphysema during hospitalization. Chest CT andclinical findings were discussed, and a literature review is presented. The probable cause of SP in COVID-19 was alveolar damage. Once pneumothorax and SP were present, the patient shoul
    Document: Coronavirus Disease 2019 (COVID-19) has rapidly spread worldwide. Numerous studies have shown its typical and atypical CT findings. We report one COVID-19 patient who presented with a transient pneumothorax, spontaneous pneumomediastinum (SP), as well as subcutaneous emphysema during hospitalization. Chest CT andclinical findings were discussed, and a literature review is presented. The probable cause of SP in COVID-19 was alveolar damage. Once pneumothorax and SP were present, the patient should be carefully monitored to prevent respiratory deterioration, especially when lung lesions are severe.

    Search related documents:
    Co phrase search for related documents
    • liver test and lung involvement: 1
    • liver test and lung lesion: 1
    • liver test and lymphocyte count: 1, 2, 3
    • low dose methylprednisolone and lymphocyte count: 1
    • lung involvement and lymphadenopathy pericardial effusion: 1, 2, 3
    • lung involvement and lymphadenopathy pericardial effusion pleural effusion: 1, 2, 3
    • lung involvement and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
    • lung involvement and lymphocyte count lymphocyte ratio: 1, 2, 3
    • lung involvement and lymphocyte ratio: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • lung lesion and lymphocyte count: 1, 2, 3, 4, 5, 6
    • lung lesion and lymphocyte count lymphocyte ratio: 1, 2
    • lung lesion and lymphocyte ratio: 1, 2